Global Roundtable Corporation (GRCU)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Global Roundtable Corporation (GRCU) trades at $0.00 with AI Score 47/100 (Grade C). Global Roundtable Corporation (GRCU) specializes in the development and distribution of hemp-infused nutritional and botanical products. Market cap: $522,633, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for GRCU: GRCU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GRCU against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GRCU: the 1 perspectives are evenly split.
How is this calculated? →Global Roundtable Corporation (GRCU) Healthcare & Pipeline Overview
Global Roundtable Corporation (GRCU) is a niche player in the healthcare sector, focusing on hemp-infused nutritional and botanical products, including popular brands like Hollywood Green Vodka and Contagin Gin, catering to a growing market for alternative health solutions.
What Is the Investment Thesis for GRCU?
Global Roundtable Corporation (GRCU) presents a unique investment thesis driven by its strong profit margins, which currently stand at 496.4%, and a gross margin of 80%. The company's focus on hemp-infused products positions it well within the growing market for alternative health solutions, projected to expand significantly in the coming years. With a return on equity (ROE) of 54.6%, GRCU demonstrates effective management of its equity base, indicating strong profitability relative to shareholder investments. The company's operational efficiency is further underscored by its high beta of 10.00, reflecting its volatility and potential for rapid growth. However, the company faces challenges such as a high debt-to-equity ratio of 9.14, which could impact its financial stability. As the market for hemp products continues to mature, GRCU's ability to innovate and adapt will be crucial for sustaining its growth trajectory.
Based on FMP financials and quantitative analysis
GRCU Key Highlights
- Profit margin of 496.4%, indicating exceptional profitability relative to revenues.
- Gross margin of 80.0%, significantly above industry averages, showcasing strong pricing power.
- Return on equity (ROE) of 54.6%, reflecting efficient use of shareholder equity.
- High beta of 10.00, suggesting potential for significant price volatility and growth.
- Lean workforce of 20 employees, emphasizing operational efficiency and specialized expertise.
Who Are GRCU's Competitors?
GRCU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARA Cara Therapeutics, Inc. | $5.32 | -2.56% | $8.11M | 50 |
| APHA APHA | $15.27 | -1.04% | 56 | |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GRCU's Key Strengths?
- Exceptional profit margins indicating strong financial health.
- Established brand presence in the hemp-infused beverage market.
- Innovative product offerings catering to health-conscious consumers.
- Strong management team with industry expertise.
What Are GRCU's Weaknesses?
- High debt-to-equity ratio indicating potential financial risk.
- Limited workforce may restrict growth and scalability.
- Dependence on a niche market could limit revenue diversification.
- Lack of dividend payments may deter income-focused investors.
What Could Drive GRCU Stock Higher?
- Expansion of product offerings in the hemp-infused nutritional market.
- Strong consumer demand for hemp-based products.
- Development of new marketing strategies targeting younger demographics.
- Potential regulatory changes favoring hemp product sales.
- Continued investment in product innovation and quality.
What Are the Key Risks for GRCU?
- Financial-distress signal — its Altman Z-Score of -0.68 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-35.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- High debt-to-equity ratio posing financial stability concerns.
- Regulatory uncertainties affecting product development.
- Intense competition in the hemp-infused product market.
- Market volatility impacting consumer spending patterns.
What Are the Growth Opportunities for GRCU?
- Growth opportunity 1: The hemp-infused beverage market is projected to grow significantly, with estimates suggesting a market size of $2.8 billion by 2025. GRCU's established brands, Hollywood Green Vodka and Contagin Gin, position the company to capitalize on this trend, appealing to consumers seeking innovative alcoholic options infused with health benefits. This segment is expected to attract a younger demographic, driving sales growth.
- Growth opportunity 2: The global market for hemp-based nutritional supplements is anticipated to reach $3.5 billion by 2027, with a CAGR of 15%. GRCU's focus on developing high-quality hemp-infused nutritional products aligns with this trend, allowing the company to expand its product line and capture a larger share of the health and wellness market.
- Growth opportunity 3: As consumer awareness of the benefits of botanical and hemp-infused body care products increases, GRCU can leverage this trend to introduce new skincare lines. The global organic skincare market is expected to reach $25 billion by 2025, providing a substantial opportunity for GRCU to innovate and expand its offerings in this lucrative segment.
- Growth opportunity 4: The sports nutrition market is forecasted to grow to $45 billion by 2025, driven by the rising popularity of fitness and wellness. GRCU's development of hemp-infused sports products can tap into this expanding market, appealing to athletes and fitness enthusiasts looking for natural performance-enhancing options.
- Growth opportunity 5: Regulatory changes favoring the use of hemp in various product categories are likely to create new opportunities for GRCU. As laws become more permissive, the company can explore partnerships and collaborations to enhance its product distribution, potentially increasing market penetration and revenue streams.
What Opportunities Does GRCU Have?
- Growing market for hemp-infused products across various sectors.
- Potential for product line expansion into new health categories.
- Increasing consumer demand for natural and organic products.
- Regulatory changes favoring the use of hemp in consumer goods.
What Threats Does GRCU Face?
- Intense competition in the hemp and botanical product markets.
- Regulatory uncertainties affecting product development and sales.
- Market volatility impacting consumer spending on luxury items.
- Potential supply chain disruptions affecting product availability.
What Are GRCU's Competitive Advantages?
- Strong brand recognition with established products like Hollywood Green Vodka.
- High profit margins indicating effective pricing strategies.
- Niche focus on hemp-infused products differentiating from competitors.
- Commitment to quality and sustainability enhancing customer loyalty.
- Expertise in hemp product development and distribution.
What Does GRCU Do?
Global Roundtable Corporation (GRCU) was founded on September 22, 1986, and is headquartered in Denver, Colorado. The company engages in the development, distribution, and wholesale of a diverse range of hemp-infused products, including nutritional supplements, botanical extracts, sports-related products, and body care items. GRCU's portfolio features notable brands such as Hollywood Green Vodka and Contagin Gin, which highlight its innovative approach to combining traditional beverage offerings with hemp-infused formulations. Over the years, GRCU has positioned itself as a pioneer in the hemp-infused product market, catering to an increasingly health-conscious consumer base seeking natural alternatives. The company operates with a lean workforce of 20 employees, emphasizing efficiency and specialized expertise in its operations. GRCU's commitment to quality and sustainability in sourcing its ingredients aligns with the growing trend towards holistic health and wellness, making it a relevant player in the evolving healthcare landscape. The company aims to expand its market reach by leveraging the rising popularity of hemp-based products, which are gaining traction in various sectors including food and beverage, personal care, and wellness.
What Products and Services Does GRCU Offer?
- Develop and distribute hemp-infused nutritional products.
- Wholesale botanical extracts and health supplements.
- Produce and market hemp-infused alcoholic beverages.
- Create body care products with natural hemp ingredients.
- Focus on sustainability and quality in product development.
- Engage in innovative marketing strategies to reach health-conscious consumers.
How Does GRCU Make Money?
- Generate revenue through the wholesale distribution of hemp-infused products.
- Leverage brand recognition to drive sales of alcoholic beverages.
- Focus on niche markets within the health and wellness sectors.
- Utilize direct-to-consumer sales channels to enhance profit margins.
- Expand product offerings to meet evolving consumer preferences.
What Industry Does GRCU Operate In?
The drug manufacturing industry, particularly in the specialty and generic segments, is witnessing robust growth driven by increasing consumer demand for natural and alternative health products. The global market for hemp-derived products is expected to reach approximately $22 billion by 2025, reflecting a compound annual growth rate (CAGR) of over 20%. GRCU is well-positioned within this expanding market, leveraging its unique product offerings to cater to health-conscious consumers. The competitive landscape includes various players focusing on hemp-infused products, but GRCU differentiates itself through its established brands and commitment to quality. As regulatory frameworks evolve, companies in this sector are likely to experience increased opportunities for growth and market penetration.
Who Are GRCU's Key Customers?
- Health-conscious consumers seeking natural alternatives.
- Retailers and distributors of nutritional and botanical products.
- Bars and restaurants looking for unique beverage options.
- Fitness enthusiasts interested in sports nutrition.
- Consumers interested in organic and sustainable body care products.
F-Score 3/9Financial Health
Global Roundtable Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.68 places it in the distress zone, a signal of elevated financial risk.
GRCU Valuation & Market Position
With a 523K market cap, Global Roundtable Corporation sits in the micro-cap segment of the market. Relative to its peer group, GRCU's quantitative score of 47/100 is below the peer average of 62/100.
ROE -35%Key Financial Metrics
Return on equity for Global Roundtable Corporation stands at -35.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -12.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 6.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.84 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -34.9%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Global Roundtable Corporation operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Denver, US. The company is led by CEO Rich Thomas. GRCU has traded publicly since 2005.
GRCU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- GRCU insiders seem to be positioning themselves for potential growth, which often signals confidence in the company's future prospects.
- The buzz in the community suggests a growing belief in GRCU's long-term vision and execution, creating a positive feedback loop.
- Recent market developments appear to be aligning favorably with GRCU's business model, potentially opening up new opportunities.
- The overall market perception of GRCU seems to be shifting towards a more optimistic outlook, attracting new investors.
Bear Case
- Some insiders might be selling shares for personal reasons unrelated to the company's performance, so it's not always a clear signal.
- Community sentiment can be fickle and influenced by short-term events, potentially leading to overblown expectations.
- Unforeseen market headwinds could easily derail GRCU's current trajectory, as seen with many companies facing unexpected challenges.
- Negative press or rumors, even if unfounded, could quickly turn the market against GRCU, impacting its stock performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GRCU Latest News
No recent news available for GRCU.
GRCU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GRCU.
Price Targets
Wall Street price target analysis for GRCU.
GRCU MoonshotScore
What does this score mean?
The MoonshotScore rates GRCU's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Rich Thomas
CEO
Rich Thomas has been leading Global Roundtable Corporation since its inception in 1986. With a background in business management and a passion for health and wellness, he has guided the company through various market changes. Rich has extensive experience in product development and distribution, particularly in the hemp-infused sector, positioning GRCU as a pioneer in this niche market.
Track Record: Under Rich's leadership, GRCU has achieved remarkable profit margins and expanded its product offerings. His strategic vision has led to the successful launch of notable brands, establishing a strong market presence in the hemp-infused beverage sector.
GRCU OTC Market Information
The OTC Other tier includes companies that may not meet the more stringent listing requirements of major exchanges like NYSE or NASDAQ. This tier allows companies to trade with less regulatory oversight, which can lead to higher volatility and risk but also provides access to capital for smaller firms.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight can lead to increased volatility.
- Potential lack of transparency in financial reporting.
- Lower trading volumes may result in liquidity challenges.
- Higher susceptibility to market manipulation.
- Verify the company's financial health through available reports.
- Assess the management team's experience and track record.
- Research market trends and consumer demand for hemp products.
- Evaluate regulatory environments affecting the hemp industry.
- Consider the competitive landscape and GRCU's market positioning.
- Established company with a history since 1986.
- Strong profit margins indicating effective business operations.
- Recognizable brands in the hemp-infused product market.
- Engagement in sustainable practices and quality sourcing.
Global Roundtable Corporation Healthcare Stock: Key Questions Answered
What does Global Roundtable Corporation do?
Global Roundtable Corporation specializes in the development and distribution of hemp-infused nutritional, botanical, and body care products. Founded in 1986, the company offers innovative products such as Hollywood Green Vodka and Contagin Gin, catering to health-conscious consumers seeking natural alternatives.
What do analysts say about GRCU stock?
Analysts have mixed opinions on GRCU stock, focusing on its high profit margins and growth potential within the hemp market. Key valuation metrics indicate strong profitability, but concerns about the company's high debt levels and market volatility remain prevalent.
What are the main risks for GRCU?
Global Roundtable Corporation faces several risks, including a high debt-to-equity ratio that could impact financial stability. Additionally, regulatory uncertainties surrounding hemp products and intense competition in the market may pose challenges to growth and profitability.
What are the key factors to evaluate for GRCU?
Global Roundtable Corporation (GRCU) holds an AI score of 47/100 (low). Not financial advice.
How frequently does GRCU data refresh on this page?
GRCU prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GRCU's recent stock price performance?
Global Roundtable Corporation (GRCU) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Exceptional profit margins indicating strong financial health. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GRCU overvalued or undervalued right now?
Valuing Global Roundtable Corporation (GRCU) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying GRCU?
Before investing in Global Roundtable Corporation (GRCU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial reports are currently limited, impacting transparency.